European Heart Journal Advance Access originally published online on July 31, 2007
European Heart Journal 2007 28(19):2415-2416; doi:10.1093/eurheartj/ehm307
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Gray zone problem in athletes
Department of Sports Medicine
Istanbul Faculty of Medicine
Istanbul University
Resitpasa caddesi Salkim sokak, No. 2/5 (PK 9) Avcilar
Istanbul 34840
Turkey
Tel: +90 216 3405316 Fax: +90 216 3405316 E-mail address: ekasikcioglu@yahoo.com
| The first 10% of the full text of this article appears below. |
Sudden death is the most unpleasant complication of hypertrophic cardiomyopathy (HCM), which is the leading cause of cardiac death in athletes. The accurate diagnosis of HCM is a more important problem than its risk stratification profile.1,2 An early and correct diagnosis of HCM, particularly in asymptomatic subjects, is crucial during